SYSPRO Welcomes Proposed FDA Regulations
Published: Aug 25, 2010
COSTA MESA, Calif.--(BUSINESS WIRE)--SYSPRO, the leading provider of visionary, pragmatic ERP software, today announced that the company is highly confident that the SYSPRO ERP solution will enable pharmaceutical manufacturers to meet the new U.S. Food and Drug Administration (FDA) regulations being proposed by Congress. The Drug Safety and Accountability Act of 2010 will strengthen quality pharmaceutical standards with stringent oversight on suppliers, manufacturers and their supply chains. The bill would require manufacturers to establish additional procedures to ensure the quality of safety drugs and drug components. It also would require companies to document the components in the drug manufacturing supply chain. The new Act is follow-through on the part of FDA executives who promised to strengthen inspection and quality requirements for drug makers who outsource to suppliers. As a result of these changes, many pharmaceutical manufacturers are looking to companies like SYSPRO to supply them with ERP systems to facilitate both the management and meeting of these new standards.